menu
    • menu

    Company profile for Clarity Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Established in 2010, Clarity is a Sydney-based life sciences company that utilises its radio-pharmaceutical capability to produce safer and more effective medicines to improve patient outcomes. Clarity’s technology, developed in collaboration with the Australian Nuclear Science and Technology Organisation (ANSTO) and the University of Melbourne, allows biopharmaceuticals to be radiolabelled for therapy as well as visualis...
    Established in 2010, Clarity is a Sydney-based life sciences company that utilises its radio-pharmaceutical capability to produce safer and more effective medicines to improve patient outcomes. Clarity’s technology, developed in collaboration with the Australian Nuclear Science and Technology Organisation (ANSTO) and the University of Melbourne, allows biopharmaceuticals to be radiolabelled for therapy as well as visualised using PET imaging. The imaging data generated provides powerful information on targeting, clearance and biodistribution of the product, which aids in drug development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Clarity PharmaceuticalsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    National Innovation Centre, 4 Cornwallis Street, Sydney, NSW 2015, AU
    Telephone
    Telephone
    +61 (0)2 9209 4037
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.claritypharmaceuticals.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clarity-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clarity Signs Copper-67 Supply Agreement With Nusano
    Clarity Signs Copper-67 Supply Agreement With Nusano

    16 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/clarity-signs-copper-67-supply-agreement-with-nusano-302585704.html

    PR NEWSWIRE
    16 Oct 2025
    Share Share
    CO-PSMA Trial Achieves Primary Endpoint
    CO-PSMA Trial Achieves Primary Endpoint

    14 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/co-psma-trial-achieves-primary-endpoint-302582639.html

    PR NEWSWIRE
    14 Oct 2025
    Share Share
    Co-PSMA trial: Recruitment successfully completed
    Co-PSMA trial: Recruitment successfully completed

    17 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/co-psma-trial-recruitment-successfully-completed-302507720.html

    PR NEWSWIRE
    17 Jul 2025
    Share Share
    Cu-64 SAR-Bombesin Detects Prostate Cancer Recurrence
    Cu-64 SAR-Bombesin Detects Prostate Cancer Recurrence

    13 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sabre-topline-results-cu-64-sar-bombesin-is-effective-in-detecting-prostate-cancer-recurrence-in-patients-with-negative-soc-imaging-302480940.html

    PR NEWSWIRE
    13 Jun 2025
    Share Share
    Indoco Launches Ticagrelor Tablets 90mg in UK Market
    Indoco Launches Ticagrelor Tablets 90mg in UK Market

    04 Jun 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/indoco-launches-ticagrelor-film-coated-tablets-90mg-in-the-uk-market/

    EXPRESSPHARMA
    04 Jun 2025
    Share Share
    First Patient Imaged in Ph III Trial of 64Cu-SAR-bisPSMA PET/CT
    First Patient Imaged in Ph III Trial of 64Cu-SAR-bisPSMA PET/CT

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/first-patient-imaged-in-phase-iii-amplify-trial-with-64cu-sar-bispsma-petct-302467836.html

    PR NEWSWIRE
    28 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search